Return to site

New Study in JAMA Oncology Points to Significant Telemedicine Benefits

Section image

Dr. Peter “Pete” Killcommons is an established Northern California telemedicine and teleradiology entrepreneur who leads Medweb and provides innovative medical solutions worldwide. Having personally worked to expand his company’s markets in locations from Cape Verde, Africa, to Japan, Dr. Peter Killcommons has a strong knowledge of industry trends.

As reported in the Washington Examiner, a study recently published in the American Medical Association's JAMA Oncology brought focus to the significant potential telemedicine has in improving quality of patient life and reducing time spent in the hospital.

With these benefits particularly felt among late-stage cancer patients, a key element is remote technologies that enable the continuous monitoring of vital signs. Alerts are generated when symptoms of potential issues, such as pain and shortness of breath, arise. Without needing to leave home and visit a medical center, patients are able to connect seamlessly with specialists through a video conference.
The JAMA findings are described as boosting bipartisan efforts in Congress to pass the Telehealth Innovation and Improvement Act of 2019, which would create new assessments and standards for telehealth services provided to Medicare beneficiaries.